SubscribeJapanese regulators Ministry of Health, Labor and Welfare (MHLW), Pharmaceuticals and Medical Devices Agency (PMDA) and the Japan Pharmaceutical Manufacturers Association (JPMA) have endorsed the Drug Information Association's (DIA) upcoming Congress on the Development and Utilisation of Pharmaceuticals.
The event, DIA’s very first multi-track workshop in Japan, will be held September 29 – 30, 2005 at the Tokyo Conference Center – Shinagawa, Area Shinagawa.
This two-day meeting will focus on how to manage and conduct simultaneous new drug developments for the global market. The complete meeting program will be available on June 29 at DIA’s Web site (www.diahome.org).
“We are excited and honored to receive the endorsements of such highly respected industry organizations,” said Hiroyuki Usuki, director of DIA’s Japan office. “The diverse program for DIA’s Congress on the Development and Utilization of Pharmaceuticals sets an aggressive agenda that will be of great interest to industry professionals looking to broaden their knowledge on timely topics.”
The meeting is composed of three concurrent tracks: Moving Towards eRegulation (Track A), Risk Management – Safety and Efficacy (Track B), and Biostatistics (Track C). Select content for these tracks consists of a cross-section of previous conventional workshops in Japan offered by DIA, such as Regulatory Affairs, Medical Writing, Medicinal Information Processing, Electronic Document Management, Global Pharmacovigilance, Pharmacogenomics and Biostatistics.
The opening keynote address will be given by Dr. Tatsuo Kurokawa, Councilor (Pharmaceutical), Minister’s Secretariat of the MHLW. Following the keynote, representatives from Japan, the United States and the European Union will participate in Issues for Simultaneous Drug Registration, an opening panel discussion presenting the key issues for global new drug development.
Reduced “early bird” rates will be available until August 29th for all registrants. For more information, please visitwww.diahome.org.
About the Drug Information Association
The Drug Information Association serves over 25,000 professionals in the biotechnology, pharmaceutical and regulatory industries worldwide. Through its domestic and international meetings, training courses and workshops, the DIA provides a neutral, global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, Pa., USA, the association is led by its volunteer-based Board of Directors and executive management team. For more information, please visit www.diahome.org or call +1 215 442 6100.